🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#IGCS2023 @Seoul

Adding immunotherapy to first-line treatment of advanced and metastati... sciencedirect.com/science/articl…

Just out in Annals of Oncology, a review and meta-analysis by Giorgio Bogani and coll. of phase III trials investigating the role of immunotherapy in the first-line setting for advanced or recurrent endometrial cancer. annalsofoncology.org/article/S0923-… 1/2 Istituto Tumori

Invite all to listen! This is “golden information” Everything you wish to know about #mirvetuximab Giorgio Bogani IJGC IJGC Fellows ESGO IGCS SGO Houston Methodist

Thanks to Giorgio Bogani for the amazing discussion on #Mirvetuximab #Soravtansine-gynx in advanced/recurrent #OvarianCancer in today's #IJGCclub! Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc

JGO editors met in KSGO! See you all next time 🌊🌊💙 KSGO

The article by Giorgio Bogani and coll. on immunotherapy in advanced endometrial cancer is the Annals of Oncology March 2024 issue article of the month ⭐️ A tutorial 🧵 1/8

The podcast is now available on open.spotify.com/episode/3HlxTY… #immunotherapy #endometrial #cancer

🆕The latest Annals of Oncology article of the month podcast 🎙️ is out! EiC Tom Powles discusses with Giorgio Bogani the role of immunotherapy in the 1st-line setting for advanced endometrial cancer. Soundcloud: soundcloud.com/esmo-podcasts/… Spotify: open.spotify.com/episode/3HlxTY…

Sagrada Familia 🥰

Save the Date! 🗓️ Join us at #ESGO2025, Europe's premier Gynaecological oncology Congress, in Rome, from Feb 20-23. Discover the latest advancements in women's health and connect with industry leaders. #ESGO #Rome #GynaecologicalOncology #HealthcareCongress enygo de la cruz @engage.esgo

Extremely proud to see the FINAL analysis of the LACC trial Journal of Clinical Oncology Worse OS at 4.5 years for #MIS Rates of carcinomatosis as recurrence 26% for MIS vs 0% for open surgery!! Houston Methodist IGCS ESGO IJGC IJGC Fellows

The IGCS 2024 Board of Directors Election is open through June 15, 2024. The candidates for Board Member (Europe) are Prof. Giorgio Bogani and Prof. Christina Fotopoulou. Learn more here: igcs.org/board-of-direc…

#PROMETrial Predicting the risk of #nodal disease in #EndometrialCancer using #histological & #molecular features 🧬 by Giorgio Bogani 📜 bit.ly/3XCEJjY Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert

#LeadArticle MIS or open surgery in patients with low-risk #cervicalcancer #SHAPEtrial subanalysis 🔍 bit.ly/4iXSp1L Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc Thomas Bartl

Check out this insightful review 📚📢 Incorporating immune checkpoint inhibitors in epithelial ovarian cancer - Gynecologic Oncology gynecologiconcology-online.net/article/S0090-… Giorgio Bogani DrKatyMoore Ray-Coquard Isabelle Jean Emmanuel Kurtz SGO

I’m so proud to launch the Italian version of Olivia at #ESGO2025 today! Olivia is a digital support tool for our ovarian cancer patients & their loved ones that guides them through diagnosis & treatment. ovarian.gynecancer.org/it

📢 SUROVA Study presented at Best Oral Presentation at ESGO Congress: •NACT: Initial benefits, especially in Asians. •PDS: Long-term survival advantage without complications. •Complications: Impact survival. •Personalized treatment is key. #ESGO #ovarian cancer

🚀 In the SUROVA study, we designed a Risk Calculator that estimates the risk of recurrence or death based on independent variables obtained through logistic regression Try it here: surovatrial.github.io/SUROVA-Risk-Ca… or scan this QR. #ESGO #SUROVA #OvarianCancer #RiskCalculator

HPV affects everyone... Today is the International #HPVAwarenessday 📄 Get informed 💉 Get vaccinated 🗣️ Spread the word #OneLessWorry Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc Thomas Bartl